- Business Wire•3 hours agoCelgene Corporation, Dana-Farber Cancer Institute and University of Arkansas for Medical Sciences Establish the Myeloma Genome Project
Celgene Corporation , Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences today announced the creation of the Myeloma Genome Project, a collaborative initiative aimed at compiling the largest dataset of high-quality genomic and clinical data to identify distinct molecular disease segments within multiple myeloma to advance diagnosis, prognosis and treatment of multiple ...
- Motley Fool•14 hours ago
Following Donald Trump's election and ahead of the release of early-stage data for its multiple myeloma drug bb2121, investor optimism soared.
- Motley Fool•yesterday
The exciting race to develop the first CAR-T therapy recently took some unexpected twists for Juno Therapeutics, bluebird bio, and Kite Pharma.
CELG : Summary for Celgene Corporation - Yahoo Finance
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||117.40 x 400|
|Ask||117.63 x 200|
|Day's Range||117.23 - 119.39|
|52 Week Range||93.05 - 127.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||44.68|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|